These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 27448975

  • 21. Silicon Phthalocyanines Axially Disubstituted with Erlotinib toward Small-Molecular-Target-Based Photodynamic Therapy.
    Chen JJ, Huang YZ, Song MR, Zhang ZH, Xue JP.
    ChemMedChem; 2017 Sep 21; 12(18):1504-1511. PubMed ID: 28776965
    [Abstract] [Full Text] [Related]

  • 22. Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer.
    Zhang J, Zhang S, Liu Y, Su M, Ling X, Liu F, Ge Y, Bai M.
    Photodiagnosis Photodyn Ther; 2018 Dec 21; 24():185-191. PubMed ID: 30240926
    [Abstract] [Full Text] [Related]

  • 23. Fibronectin-Targeting and Cathepsin B-Activatable Theranostic Nanoprobe for MR/Fluorescence Imaging and Enhanced Photodynamic Therapy for Triple Negative Breast Cancer.
    Wang Y, Jiang L, Zhang Y, Lu Y, Li J, Wang H, Yao D, Wang D.
    ACS Appl Mater Interfaces; 2020 Jul 29; 12(30):33564-33574. PubMed ID: 32633941
    [Abstract] [Full Text] [Related]

  • 24. 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models.
    Kasten BB, Oliver PG, Kim H, Fan J, Ferrone S, Zinn KR, Buchsbaum DJ.
    Int J Mol Sci; 2018 Mar 21; 19(4):. PubMed ID: 29561763
    [Abstract] [Full Text] [Related]

  • 25. An immunoconjugated up-conversion nanocomplex for selective imaging and photodynamic therapy against HER2-positive breast cancer.
    Ramírez-García G, Panikar SS, López-Luke T, Piazza V, Honorato-Colin MA, Camacho-Villegas T, Hernández-Gutiérrez R, De la Rosa E.
    Nanoscale; 2018 May 31; 10(21):10154-10165. PubMed ID: 29785440
    [Abstract] [Full Text] [Related]

  • 26. Cancer targeting with biomolecules: a comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles.
    Obaid G, Chambrier I, Cook MJ, Russell DA.
    Photochem Photobiol Sci; 2015 Apr 31; 14(4):737-47. PubMed ID: 25604735
    [Abstract] [Full Text] [Related]

  • 27. EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.
    van Driel PBAA, Boonstra MC, Slooter MD, Heukers R, Stammes MA, Snoeks TJA, de Bruijn HS, van Diest PJ, Vahrmeijer AL, van Bergen En Henegouwen PMP, van de Velde CJH, Löwik CWGM, Robinson DJ, Oliveira S.
    J Control Release; 2016 May 10; 229():93-105. PubMed ID: 26988602
    [Abstract] [Full Text] [Related]

  • 28. Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer.
    Zhang M, Kim HS, Jin T, Moon WK.
    J Photochem Photobiol B; 2017 May 10; 170():58-64. PubMed ID: 28390259
    [Abstract] [Full Text] [Related]

  • 29. Remotely Phototriggered, Transferrin-Targeted Polymeric Nanoparticles for the Treatment of Breast Cancer.
    Jadia R, Kydd J, Rai P.
    Photochem Photobiol; 2018 Jul 10; 94(4):765-774. PubMed ID: 29427385
    [Abstract] [Full Text] [Related]

  • 30. Discovery of N-(Naphtho[1,2-b]Furan-5-Yl) Benzenesulfonamides as Novel Selective Inhibitors of Triple-Negative Breast Cancer (TNBC).
    Chen Y, Tang Y, Mao B, Li W, Jin H, Zhang L, Liu Z.
    Molecules; 2018 Mar 16; 23(3):. PubMed ID: 29547591
    [Abstract] [Full Text] [Related]

  • 31. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
    Thakkar A, Wang B, Picon-Ruiz M, Buchwald P, Ince TA.
    Breast Cancer Res Treat; 2016 May 16; 157(1):77-90. PubMed ID: 27120467
    [Abstract] [Full Text] [Related]

  • 32. Ultrasound-targeted photodynamic and gene dual therapy for effectively inhibiting triple negative breast cancer by cationic porphyrin lipid microbubbles loaded with HIF1α-siRNA.
    Sun S, Xu Y, Fu P, Chen M, Sun S, Zhao R, Wang J, Liang X, Wang S.
    Nanoscale; 2018 Nov 01; 10(42):19945-19956. PubMed ID: 30346453
    [Abstract] [Full Text] [Related]

  • 33. C-MYC and C-FOS expression changes and cellular aspects of the photodynamic reaction with photosensitizers TMPyP and ClAlPcS2.
    Pizova K, Bajgar R, Fillerova R, Kriegova E, Cenklova V, Langova K, Konecny P, Kolarova H.
    J Photochem Photobiol B; 2015 Jan 01; 142():186-96. PubMed ID: 25545333
    [Abstract] [Full Text] [Related]

  • 34. Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development.
    Costa R, Shah AN, Santa-Maria CA, Cruz MR, Mahalingam D, Carneiro BA, Chae YK, Cristofanilli M, Gradishar WJ, Giles FJ.
    Cancer Treat Rev; 2017 Feb 01; 53():111-119. PubMed ID: 28104566
    [Abstract] [Full Text] [Related]

  • 35. Pharmaceutical development, composition and quantitative analysis of phthalocyanine as the photosensitizer for cancer photodynamic therapy.
    Jiang Z, Shao J, Yang T, Wang J, Jia L.
    J Pharm Biomed Anal; 2014 Jan 01; 87():98-104. PubMed ID: 23746989
    [Abstract] [Full Text] [Related]

  • 36. Recent Advances in Activatable Organic Photosensitizers for Specific Photodynamic Therapy.
    Liu M, Li C.
    Chempluschem; 2020 May 01; 85(5):948-957. PubMed ID: 32401421
    [Abstract] [Full Text] [Related]

  • 37. An Investigation into the In Vitro Targeted Killing of CD44-Expressing Triple-Negative Breast Cancer Cells Using Recombinant Photoimmunotherapeutics Compared to Auristatin-F-Based Antibody-Drug Conjugates.
    Mungra N, Nsole Biteghe FA, Huysamen AM, Hardcastle NS, Bunjun R, Naran K, Lang D, Richter W, Hunter R, Barth S.
    Mol Pharm; 2024 Aug 05; 21(8):4098-4115. PubMed ID: 39047292
    [Abstract] [Full Text] [Related]

  • 38. Antitumor immunity induced by the photodynamic action of BAM-SiPc, a silicon (IV) phthalocyanine photosensitizer.
    Zhang Y, Ng DKP, Fong WP.
    Cell Mol Immunol; 2019 Jul 05; 16(7):676-678. PubMed ID: 31076728
    [No Abstract] [Full Text] [Related]

  • 39. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M, Chakrabarti R, Kongara S, Price S, Nahar R, Lozy F, Zhong H, Vazquez A, Kang Y, Karantza V.
    Autophagy; 2014 Jul 05; 10(11):2036-52. PubMed ID: 25483966
    [Abstract] [Full Text] [Related]

  • 40. Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates.
    Stuchinskaya T, Moreno M, Cook MJ, Edwards DR, Russell DA.
    Photochem Photobiol Sci; 2011 May 05; 10(5):822-31. PubMed ID: 21455532
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.